Different cardiovascular effects of progestins according to structure and activity
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Following the publication of the Women's Health Initiative study, the controversy was raised regarding the role of progestins in hormonal replacement therapy (HRT). Some of the most prescribed molecules, with partial androgenic or glucocorticoid activity, have been shown to oppose partially the beneficial effect of estrogens on surrogate markers of cardiovascular disease risk. Unfortunately, this concern has been directed towards progestins as a class effect, although striking differences exist among the types of molecules used. The synthetic progestins used in HRT have varying pharmacologic properties depending on the molecules from which they are derived, either testosterone or progesterone. Very small structural changes in these molecules may induce considerable difference in their effects on various targets and especially on the surrogate markers of cardiovascular disease risk, where some molecules may reverse the beneficial effects of estrogen. Natural progesterone and some of its derivatives such as the 19-norprogesterone molecules or the new molecules drospirenone, a potent antimineralocorticoid agent with a beneficial effect on blood pressure, and dienogest do not exert any androgenic effect and have no negative effect on the lipids or on the endothelial cells. Although it is likely that the new progestins may be neutral on the coronary disease risk, when administered to the younger postmenopausal woman, this has not as yet been documented by large, randomized, contro…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Taken together, the volume expanding effects of OCs and the resultant effects on blood pressure appear to predominate.”
From Oral contraceptive use, muscle sympathetic nerve activity, and systemic hemodynamics in young women (2015) · cites this paper as [49]
In the citing paper
“As discussed above, OCs containing the progestin drospirenone, which has high antimineralocorticoid activity, will promote urinary loss of water and sodium and thereby reduce blood pressure.49”
From Oral contraceptive use, muscle sympathetic nerve activity, and systemic hemodynamics in young women (2015) · cites this paper as [49]
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
The Protective Effects of Estrogen on the Cardiovascular System
Mendelsohn, M. E., & Karas, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402306 · Cited by 3,103
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
New progestagens for contraceptive use
Sitruk-Ware, R. (2006) · Human Reproduction Update · doi:10.1093/humupd/dmi046 · Cited by 362
Self-citationHerkert, O., Kuhl, H., Sandow, J., Busse, R., & Schini-Kerth, V. B. (2001) · Circulation · doi:10.1161/hc4801.099737 · Cited by 120
White, W. B., Pitt, B., Preston, R. A., & Hanes, V. (2005) · Circulation · doi:10.1161/circulationaha.104.501502 · Cited by 108
Progestins and cardiovascular risk markers
Sitruk-Ware, R. L. (2000) · Steroids · doi:10.1016/s0039-128x(00)00174-4 · Cited by 78
Self-citationConard, J., Basdevant, A., Thomas, J.-L., Ochsenbein, E., Denis, C., Guyene, T. T., & Degrelle, H. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57909-6 · Cited by 74
Sitruk-Ware, R. L., Ménard, J., Rad, M., Burggraaf, J., de Kam, M. L., Tokay, B. A., Sivin, I., & Kluft, C. (2007) · Contraception · doi:10.1016/j.contraception.2007.01.027 · Cited by 61
Self-citation
Research works printed but not linked: 2
- Zerr-Fouineau M, 2008, Arterioscler Thromb Vasc Biol
- Arnal J F, 2009, Arterioscler Thromb Vasc Biol
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
Francis, G. L., Waguespack, S. G., Bauer, A. J., Angelos, P., Benvenga, S., Cerutti, J. M., Dinauer, C. A., Hamilton, J., Hay, I. D., Luster, M., et al. (2015) · Thyroid · doi:10.1089/thy.2014.0460 · Cited by 1,238
Gender and the renin–angiotensin–aldosterone system
Komukai, K., Mochizuki, S., & Yoshimura, M. (2010) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00854.x · Cited by 291
Metabolic effects of contraceptive steroids
Sitruk-Ware, R., & Nath, A. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9182-4 · Cited by 161
“Androgenic progestins have shown an adverse effect over total and HDL cholesterol [14].”
BackgroundSelf-citationPostmenopausal hormone therapy: risks and benefits
Rozenberg, S., Vandromme, J., & Antoine, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.17 · Cited by 151
Metadata
- Authors
- Nath, A., & Sitruk-Ware, R.
- Affiliations
- Population Council (US)
- Venue
- Climacteric
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 12
- Issue
- sup1
- Pages
- 96-101
- ISSN
- 1369-7137 (ISSN-L)
- 1473-0804
- OpenAlex
- W2093126216
- Cited by
- 46
- References
- 19
- Citations by year
- 2025: 2 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 1 · 2017: 1 · 2015: 6 · 2014: 3 · 2013: 4 · 2012: 6
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Climacteric (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- progestins, cardiovascular risk, hormone replacement therapy, Women's Health Initiative, androgenic activity, glucocorticoid activity, natural progesterone, 19-norprogesterone, drospirenone, dienogest, postmenopausal women, coronary artery disease, blood pressure, lipid profile, endothelial cells
- MeSH terms
- Animals, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Structure-Activity Relationship, Estrogen Replacement Therapy, Models, Animal, Progesterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Different cardiovascular effects of progestins according to structure and activity. https://app.cochat.ai/papers/10.1080/13697130902905757
- The paper
- Nath, A., & Sitruk-Ware, R. (2009). Different cardiovascular effects of progestins according to structure and activity. Climacteric. https://doi.org/10.1080/13697130902905757
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.